Early growth response 1 is an early signal inducing Cav3.2 T-type calcium channels during cardiac hypertrophy

Cardiovascular Research

Volumn 100, Issue 2, 2013, Pages 222-230

  Hsu, Shao Chun ^a,b   Chang, Ya Ting ^a   Chen, Chien Chang ^a  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Cav3.2; Cardiac hypertrophy; Egr1; T type calcium channel; Transcriptional regulation

Indexed keywords

CALCIUM CHANNEL T TYPE; CALCIUM CHANNEL T TYPE CAV3.2; EARLY GROWTH RESPONSE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA FLANKING REGION; GENE EXPRESSION; HEART LEFT VENTRICLE WALL; HEART VENTRICLE HYPERTROPHY; IN VIVO GENE TRANSFER; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION SITE; TRANSGENIC MOUSE; UPREGULATION;

CARDIAC HYPERTROPHY; CAV3.2; EGR1; T-TYPE CALCIUM CHANNEL; TRANSCRIPTIONAL REGULATION;

ANIMALS; BINDING SITES; CALCIUM CHANNELS, T-TYPE; CARDIOMEGALY; EARLY GROWTH RESPONSE PROTEIN 1; FEMALE; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED C57BL;

EID: 84886038986     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt190     Document Type: Article

References (35)

1. Frey N, Olson EN. Cardiac hypertrophy: the good, the bad, and the ugly. Ann Rev Physiol 2003;65:45-79.
2. Kuwahara K, Nishikimi T, Nakao K. Transcriptional regulation of the fetal cardiac gene program. J Pharmacol Sci 2012;119:198-203.
3. 2+ channels have different effects on myocyte contractility and induce unique cardiac phenotypes. Circ Res 2008;103:1109-1119.
4. Leuranguer V, Monteil A, Bourinet E, Dayanithi G, Nargeot J. T-type calcium currents in rat cardiomyocytes during postnatal development: contribution to hormone secretion. Am J Physiol Heart Circ Physiol 2000;279:H2540-H2548.
5. 2+ channel in murine hearts during the embryonic period. Am J Physiol Heart Circ Physiol 2004;286:H2257-H2263.
6. Bohn G, Moosmang S, Conrad H, Ludwig A, Hofmann F, Klugbauer N. Expression of Tand L-type calcium channelm RNAinmurine sinoatrial node. FEBS Lett 2000;481:73-76.
7. Mangoni ME, Traboulsie A, Leoni AL, Couette B, Marger L, Le Quang K et al. Bradycardia and slowing of the atrioventricular conduction in mice lacking CaV3.1/alpha1G T-type calcium channels. Circ Res 2006;98:1422-1430.
8. Marger L, Mesirca P, Alig J, Torrente A, Dubel S, Engeland B et al. Functional roles of Ca(v)1.3, Ca(v)3.1 and HCN channels in automaticity of mouse atrioventricular cells: insights into the atrioventricular pacemaker mechanism. Channels (Austin) 2011;5: 251-261.
9. 2+ channels. Science 2003;302: 1416-1418.
10. 2+ channels in ventricular cells from hypertrophied rat hearts. J Mol Cell Cardiol 1999;31:1617-1625.
11. Ferron L, Capuano V, Ruchon Y, Deroubaix E, Coulombe A, Renaud JF. Angiotensin II signaling pathways mediate expression of cardiac T-type calcium channels. Circ Res 2003;93:1241-1248.
12. Chiang CS, Huang CH, Chieng H, Chang YT, Chang D, Chen JJ et al. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice. Circ Res 2009;104:522-530.
13. Ferron L, Ruchon Y, Renaud JF, Capuano V. T-type Ca(2)+ signalling regulates aldosterone-induced CRE Bactivation and cell death throughPP2A activation in neonatal cardiomyocytes. Cardiovasc Res 2011;90:105-112.
14. Maturana A, Lenglet S, Python M, Kuroda S, Rossier MF. Role of the T-type calcium channel CaV3.2 in the chronotropic action of corticosteroids in isolated rat ventricular myocytes. Endocrinology 2009;150:3726-3734.
15. 2+ current antagonizes cardiac hypertrophy through a NOS3-dependent mechanism in mice. J Clin Invest 2009;119:3787-3796.
16. 2+ channel blockade prevents sudden death in mice with heart failure. Circulation 2009; 120:743-752.
17. Kuwahara K, Saito Y, Takano M, Arai Y, Yasuno S, Nakagawa Y et al. NRSF regulates the fetal cardiac gene program and maintains normal cardiac structure and function. EMBO J 2003;22:6310-6321.
18. 2+ channels in neonatal rat heart. J Mole Cell Cardiol 2007;42:1045-1053.
19. Buvoli M, Leinwand LA. Direct gene transfer into mouse heart. Method Enzymol 2002; 346:134-142.
20. von Harsdorf R, Edwards JG, Shen YT, Kudej RK, Dietz R, Leinwand LA et al. Identification of a cis-acting regulatory element conferring inducibility of the atrial natriuretic factor gene in acute pressure overload. J Clin Invest 1997;100:1294-1304.
21. Buitrago M, Lorenz K, Maass AH, Oberdorf-Maass S, Keller U, Schmitteckert EM et al. The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy. Nat Med 2005;11:837-844.
22. Ovcharenko I, Nobrega MA, Loots GG, Stubbs L. ECR Browser: a tool for visualizing and accessing data from comparisons of multiple vertebrate genomes. Nucleic Acids Res 2004; 32:W280-W286.
23. Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 1998;26: 362-367.
24. Johns DG, Ao Z, Naselsky D, Herold CL, Maniscalco K, Sarov-Blat L et al. Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators. Naunyn-Schmiedeberg's Arch Pharmacol 2004;370: 238-250.
25. Hwang GS, Oh KS, Koo HN, Seo HW, You KH, Lee BH. Effects of KR-31378, a novel ATP-sensitive potassium channel activator, on hypertrophy of H9c2 cells and on cardiac dysfunction in rats with congestive heart failure. Eur J Pharmacol 2006;540: 131-138.
26. Neyses L, Nouskas J, Luyken J, Fronhoffs S, Oberdorf S, Pfeifer U et al. Induction of immediate-early genes by angiotensin II and endothelin-1 in adult rat cardiomyocytes. J Hypertens 1993;11:927-934.
27. Patrizio M, Musumeci M, Stati T, Fecchi K, Mattei E, Catalano L et al. Propranolol promotes Egr1 gene expression in cardiomyocytes via beta-adrenoceptors. Eur J Pharmacol 2008;587:85-89.
28. Sharma HS, van Heugten HA, Goedbloed MA, Verdouw PD, Lamers JM. Angiotensin II induced expression of transcription factors precedes increase in transforming growth factor-beta 1 mRNA in neonatal cardiac fibroblasts. Biochem Biophys Res Comm 1994; 205:105-112.
29. Bruneau BG, Piazza LA, de Bold AJ. Alpha 1-adrenergic stimulation of isolated rat atria results in discoordinate increases in natriuretic peptide secretion and gene expression and enhances Egr-1 and c-Myc expression. Endocrinology 1996;137:137-143.
30. Brand T, Sharma HS, Schaper W. Expression of nuclear proto-oncogenes in isoproterenol-induced cardiac hypertrophy. J Mole Cell Cardiol 1993;25:1325-1337.
31. Saadane N, Alpert L, Chalifour LE. Expression of immediate early genes, GATA-4, and Nkx-2.5 in adrenergic-induced cardiac hypertrophy and during regression in adult mice. Br J Pharmacol 1999;127:1165-1176.
32. Holder EL, Al Moustafa AE, Chalifour LE. Molecular remodelling in hypertrophied hearts from polyomavirus large T-antigen transgenic mice. Mol Cell Biochem 1995;152: 131-141.
33. van Loo KM, Schaub C, Pernhorst K, Yaari Y, Beck H, Schoch S et al. Transcriptional regulation of T-type calcium channel CaV3.2: bi-directionality by early growth response 1 (Egr1) and repressor element 1 (RE-1) protein-silencing transcription factor (REST). J Biol Chem 2012;287:15489-15501.
34. Miao F, Li S, Chavez V, Lanting L, Natarajan R. Coactivator-associated arginine methyltransferase-1 enhances nuclear factor-kappaB-mediated gene transcription through methylation of histone H3 at arginine 17. Mol Endocrinol 2006;20:1562-1573.
35. Covic M, Hassa PO, Saccani S, Buerki C, Meier NI, Lombardi C et al. Arginine methyltransferase CARM1 is a promoter-specific regulator of NF-kappaB-dependent gene expression. EMBO J 2005;24:85-96.